J&J buys into Protagonist’s oral peptides
Monday, June 5, 2017 - 00:22
in Health & Medicine
The deal adds to the big pharma firm’s inflammatory bowel disease portfolio
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via